A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Traws Pharma, Inc. operates in the Pharmaceutical Preparations industry, Healthcare sector. Full business description from SEC filing not yet available.
| Segment | 2011 | % of Total |
|---|---|---|
SymBio | $8M | 100% |
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | 226K | - | - | - |
| Net Income | -13M | -55M | - | -19M | -16M | -25M |
| EPS | $97.19 | $-35.21 | $-22.57 | $-22.75 | $-24.00 | $-54.25 |
| Free Cash Flow | 0 | -33M | -18M | -16M | -19M | -23M |
| ROIC | -207.0% | - | - | -67.0% | -35.0% | -319.7% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | - | 1.13 | 0.39 | 0.20 | 2.24 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -16M | -142M | -20M | -20M | -16M | -25M |
| Operating Margin | 0.0% | - | -8981.4% | - | - | - |
| ROE | -107.0% | - | - | -67.0% | -35.0% | -407.4% |
| Shares Outstanding | 8M | 2M | 5M | 1M | 1M | 0M |
Traws Pharma, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
Traws Pharma, Inc. (TRAW) has a 5-year average return on invested capital (ROIC) of -51.0%. This is below average and may indicate limited pricing power.
Traws Pharma, Inc. (TRAW) has a market capitalization of $13M. It is classified as a small-cap stock.
Traws Pharma, Inc. (TRAW) does not currently pay a regular dividend.
Traws Pharma, Inc. (TRAW) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
Traws Pharma, Inc. (TRAW) generated $-33 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Traws Pharma, Inc. (TRAW) reported earnings per share (EPS) of $-35.21 in its most recent fiscal year.
The Ledger Terminal provides 13 years of financial data for Traws Pharma, Inc. (TRAW), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.